Bioimpacts

Papers
(The H4-Index of Bioimpacts is 13. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-08-01 to 2026-08-01.)
ArticleCitations
Inhibitory effect of miR342 on the progression of triple-negative breast cancer cells in vitro and in the mice model41
A cancer diagnosis transformer model based on medical IoT data for clinical measurements in predictive care systems30
Photoplethysmography based non-invasive blood glucose estimation using systolic-diastolic framing MFCC features and machine learning regression30
The role of artificial intelligence in enhancing breast cancer screening and diagnosis: A review of current advances28
Molecular dynamics simulation in tissue engineering22
Smart IoT-driven biosensors for EEG-based driving fatigue detection: A CNN-XGBoost model enhancing healthcare quality17
Advances in nanomaterials for precision drug delivery: Insights into pharmacokinetics and toxicity16
Exosomes: Redefining intercellular communication and the future of translational medicine16
Cell-imprinted substrates as biomimetic platforms for osteoarthritis modeling with mesenchymal stem cells16
Simultaneous effect of miR-21 suppression and miR-143 restoration on inhibition of proliferation and migration in SW-480 colorectal cancer cells15
Targeting long non-coding RNAs as new modulators in anti-EGFR resistance mechanisms14
Cytotoxicity of WT1-reactive T cells against Wilms tumor: An implication for antigen-specific adoptive immunotherapy13
Investigating the function and targeting of MET protein as an oncogene kinase in pancreatic ductal adenocarcinoma: A microarray data integration13
0.060285091400146